Recessive mutations of the potassium chloride co-transporter 3 gene (SLC12A6, KCC3) cause severe peripheral neuropathy frequently associated with agenesis of the corpus callosum and psychoses (ACCPN). SLC12A6 is localized on chromosome 15q14, a region where linkage to schizophrenia and bipolar disorder has previously been shown. Mutation analysis of SLC12A6 was carried out by direct sequencing of PCR-generated DNA fragments in two affected members of a multiplex family, and three non-affected individuals. A case-control study was performed to assess association of variants with bipolar disorder and schizophrenia in a large sample. Several variants including two rare single nucleotide polymorphisms (G/A, G/A) in the promoter and 5k-UTR, and a thymidine insertion in intron 4 were found. The two G variants and the insertion variant were co-inherited with chromosome 15-related schizophrenia in a large family that strongly supports the region on chromosome 15q14-15 between markers D15S144 and D15S132. Furthermore, they are in linkage disequilibrium with each other, and significantly associated with bipolar disorder in a case-control study. Our data strongly suggest that rare variants of SLC12A6 may represent risk factors for bipolar disorder.
Introduction
Cation-chloride co-transporters, including the potassium chloride co-transporters, are involved in the electroneutral movement of ions across the plasma membrane, thus controlling ionic and osmotic homeostasis of various cell types. Recently, Shen and co-workers demonstrated that expression of the potassium chloride co-transporter 3 (formerly KCC3 ; the approved symbol provided by the HUGO Gene Nomenclature Committee is SLC12A6 for solute carrier family 12, member 6) increases the cell proliferation rate (Shen et al., 2001) . Two isoforms of the co-transporter generated by alternative splicing, and designated KCC3A and KCC3B, have been described (Mount et al., 1999) . Of these, KCC3A is predominantly expressed in the brain, whereas KCC3B was found in peripheral tissues (Pearson et al., 2001 ). The gene SLC12A6 has been assigned to chromosome 15q13-14 (Hiki et al., 1999 ; Mount et al., 1999 ), a region that shows a linkage peak with the recessively inherited Andermann syndrome (peripheral neuropathy with or without agenesis of the corpus callosum, ACCPN, OMIM 218000). ACCPN is linked to the marker D15S971, which is localized in the vicinity of the connexin 36 gene (CX36) and SLC12A6 (Casaubon et al., 1996 ). Delpire and Mount (2002) suggested SLC12A6 as a candidate gene for both ACCPN and chromosome 15-related schizophrenia (SCZD10, periodic catatonia, OMIM 605419), and more recently, Howard and colleagues (2002) demonstrated that recessive mutations of SLC12A6 in fact cause ACCPN. Moreover, electrophysiological, morphological, and neuropsychological studies over the last years point to altered callosal connectivity in schizophrenics (Narr et al., 2003) , and monozygotic twins with schizophrenia associated with agenesis of the corpus callosum have been described (Motomura et al., 2002 ; for review, see Innocenti et al., 2003) .
The chromosome 15q13-15 region has recently been suggested to contain a susceptibility gene for hereditary schizophrenia Riley et al., 2000) , chromosome 15-related schizophrenia (SCZD10, periodic catatonia, OMIM 605419) (Meyer et al., 2002a ; Stö ber et al., 2000 Stö ber et al., , 2002 , schizophrenia combined with a neurophysiological trait, namely P50 auditory event-evoked potential inhibition deficit (Freedman et al., 1997 (Freedman et al., , 2001 , and lithium-responsive bipolar disorder (Turecki et al., 2001) . Previously, SLC12A6 has been considered as a candidate gene for Rolandic epilepsy and juvenile myoclonic epilepsy (EJM2, OMIM 604827) both mapping to chromosome 15q14. However, attempts to detect variants of SLC12A6 responsible for epilepsy were not successful (Steinlein et al., 2001) .
We have recently reported confirmed linkage based on a dominant model of inheritance (maximum GENEHUNTER-PLUS lod score 3.57, p=0.000026, at coordinate 35.3 cM) of polymorphic markers between D15S144 and D15S1028 with periodic catatonia (Meyer et al., 2002a ; Stö ber et al., 2000) . Periodic catatonia is a disorder characterized by recurrent episodes of psychosis and psychomotor disturbances. Patients with periodic catatonia express a fluctuating phenotype combining akinetic negativism, immobility and mutism, or hyperkinesia with stereotypies and parakinetic movements as well as increased anxiety, impulsivity and aggressiveness. It is currently conceptualized as a subtype of schizophrenia, however, it also can occur in mood disorders, especially in bipolar disorder (Taylor and Fink, 2003) .
Based on our positive linkage findings, the positional candidate CX36 (Meyer et al., 2002c) as well as the gene encoding the nicotinic a7 receptor (CHRNA7 ; Meyer et al., 2002a) were subsequently excluded as risk factors in the families with periodic catatonia. Here, we report the results of a mutation analysis of SLC12A6. We sequenced all exons, exon/intron boundaries, and the putative transcriptional control region of the gene. The aim of present study was to clarify whether a SLC12A6 mutation is involved in SCZD10, schizophrenia spectrum and bipolar disorder in a large family and other patients.
Material and methods

Patients
Members of large families were ascertained as previously described in detail by our group and others (Meyer et al., 2002a ; Stö ber et al., 2000 Stö ber et al., , 2001 Stö ber et al., , 2002 . Family 11 (Figure 1 ) consists of three generations with 10 healthy and seven members affected with periodic catatonia as depicted in Stö ber et al. (2001) and Meyer et al. (2002a) . This family strongly supports the chromosome 15q14 locus (Meyer et al., 2002a ; Stö ber et al., 2001) . Consistent diagnostic classification according to ICD-10 and the Leonhard classification (Leonhard, 1999) was achieved by extensive clinical evaluation, and additional information was collected from different sources, including case history, medical records and/or family informants.
A total of 186 patients from the Lower Franconia area in Germany participated in the association study. These subjects were ascertained either at the Department of Psychiatry and Psychotherapy, University of Wuerzburg, or at the Psychiatric District Hospital Werneck. A total of 114 patients suffered from schizophrenia spectrum disorders according to ICD-10 criteria (31 paranoid type, 14 hebephrenic type, 4 catatonic type, 5 undifferentiated type, 23 residual type, 4 schizophrenia simplex, 1 schizotypical disorder, 9 delusional disorder, 23 schizoaffective disorder). All schizophrenia spectrum disorder patients were in-patients and had been seen by an experienced psychiatrist (A.R. and/or I.T.), and extensive semistructural interviews had been conducted along with chart reviews and, if possible, further information was retrieved from family informants and case records from other hospitals to ensure consistent diagnoses. Furthermore, one affected patient from each of the 12 families investigated in our genome scan (Stö ber et al., 2000 (Stö ber et al., , 2001 was genotyped. An additional sample of 72 in-patients suffering from bipolar disorder 
(1) (66 patients) or severe depressive disorder with psychotic symptoms (six patients) according to ICD-10 criteria, were ascertained at the Department of Psychiatry, University of Wuerzburg. Bipolar patients had at least one manic and one depressive episode, and patients suffering from depression had at least two depressive episodes, and showed psychotic symptoms during these episodes. None of the subjects showed significant neurological comorbidity, epilepsy, mental retardation, or a history of substance abuse. A sample of DNA probes derived from of 350 control subjects has been collected by staff of the Departments of Psychiatry and Psychotherapy, and Transfusion Medicine of the University of Wuerzburg. The control sample consists of healthy blood donors from the same area as the patient group, which were not screened for a history of psychiatric disorders. Mean age of patients was 46¡15 yr, of controls 32¡10.5 yr. Only patients and healthy volunteers who gave written informed consent after oral and written explanation about the aim and scope of the investigation were enrolled in this study. The study was approved by the Ethics Committee of the University of Wuerzburg.
Mutation analysis
The putative transcriptional control region and all exons of SLC12A6 from two affected members of family 11 (patients 732 and 737 ; Meyer et al., 2002a) and three healthy controls were amplified in a T-Gradient thermocycler (Biometra, Gö ttingen, Germany). Annotation of the gene and primer selection was based on the sequence provided by the International Human Genome Sequencing Consortium . For these PCRs we have used 37 primer pairs ; primers and methods used for individual SNP verification not described here are available on request. PCR was performed in a final volume of 25 ml containing 40-60 ng genomic DNA, 10 pmol of each primer, 200 mM of each NTP, 0.75 or 1.5 mM MgCl 2 , 50 mM KCl, 10 mM Tris-HCl (pH 8.3 at 25 xC), 0.025 mg/ml BSA, 0.025 % Tween-20, and 0.5 U Taq DNA polymerase (Eurogentec, Seraing, Belgium). Resulting PCR products were sequenced using an ABI 310 automated sequencer (Applied Biosystems, Foster City, CA, USA). Subsequently, all family members and control subjects were tested for variants that were found to be restricted to the patients.
Genotyping
The following primer pairs were used for genotyping : For 32416574G/A, forward primer PromG/A-f : 5k-CCTGAATCAAGAAACCCAGAC-3k, reverse primer PromG/A-r : 5k-ATCCATTCCATGTTTTCACCA-3k. PCR conditions were as described above, with 0.75 mM MgCl 2 , annealing temperature 60.6 xC, product size 424 bp. For 32418760G/A, forward primer was UTR-f : 5k-TGTGGGGTATTCACCTG-3k. Variant-specific primers, ending with either C or T, were selected for the reverse strand : UTR-C-r, 5k-TTTCCTGTCGAGG-TAGC-3k, UTR-T-r, TTTCCTGTCGAGGTAGT-3k. PCR conditions were as described above, with 0.75 mM MgCl 2 , annealing temperature 52.2 xC, product size 157 bp. For IVS4+1008ins(T)/del(T), primers INS-T-f : 5k-TTTCTGCTTGGAGGTTAATATGG-3k, and INS-T-r : 5k-GAGGTAGACACCCATGAAGG-3k were used. PCR conditions were as described above, with 0.75 mM MgCl 2 , annealing temperature 59.2 xC, product sizes 145 and 146 bp.
Statistical analysis
Single marker-disease associations were calculated by exact tests, x 2 tests, and Armitage trend tests (Sasieni, 1997) using the SAS statistical package SAS/STAT, version 8.1 (SAS Institute Inc., Cary, NC, USA). Haplotype analysis was performed with the program FastEH (Zhao et al., 2000 ; Zhao and Sham, 2002) . To assess Hardy-Weinberg equilibrium of the genotypes in cases and controls, the program FINETTI (T. F. Wienker, unpublished observations) was used. Hardy-Weinberg equilibrium was confirmed for all variants in patients and controls. Pairwise haplotypes and the complete haplotype block for the three variants in the combined sample and in the two subgroups were assessed first. Subsequently, the single variants were explored for association, the p values were corrected for 12 times multiple testing. A p value of <0.0042 is, therefore, considered to be significant.
Results
The putative promoter region, a newly defined 5k-untranslated region (5k-UTR), and the coding sequence of SLC12A6 were compared between patients and controls. Variants of the predicted promoter, 5k-UTR, and the coding region are summarized in Table 1 .
Promoter and 5k-UTR
The putative promoter region of SLC12A6 as predicted by PROSCAN software version 1.7 (http ://bimas.dcrt. nih.gov/molbio/proscan/) was compared between patients and controls by sequencing. A newly defined 5k-UTR of 1185 nucleotides of exon 1A was assembled by annotation of several novel expressed sequence tag clones (ESTs) deposited in the GenBank database (GenBank accession nos. BI561477, AF477977, AF105366, BI032773, BI032775, BI463275, and Macaca fascicularis cDNA clone QtsA-15786 (GenBank accession no. AB070168) to the human genomic sequence ). Due to alternative splicing of exon 1A, parts of these sequences may either represent exonic 5k-UTR or intronic sequence. Two rare variants, 32416574G ([CTTTAC(A/G)TTAGGA], 5k-UTR) and 32418760G ([TAAAGG(A/G)CTACCT], promoter), were found in all affected members of family 11 (numbering according to UCSC Browser Golden Path of May 2004, Freeze). Additionally, one affected member of each of the remaining 11 families involved in our initial genome scan (Stö ber et al., 2000 (Stö ber et al., , 2001 was genotyped for these two variants, but neither was detected in these families.
Coding region
No variants of the coding sequence of SLC12A6 have been described so far, however, we found five coding-synonymous variants, and all five subjects investigated in the first step and an additional 30 caucasian subjects of German (n=26) and American (n=4) origin being homozygous for codon 466 TCT encoding serine (Table 1 ). This codon is in accordance with the sequence (contig accession no. NT_024680) provided by the International Human Genome Sequencing Consortium . A TTT triplet encoding phenylalanine was present in three entries deposited in the GenBank database at amino acid positions 466 (KCC3A, GenBank accession no. XM_007749 and XM_036778) and 327 (KCC3B, GenBank accession no. XM_036777) respectively. However, these putatively erroneous entries have since been removed from GenBank.
Introns
We found a T/C polymorphism [5k-GCTCTAATT-TT(T/C)CA-3'] adjacent to a putative branch site (CTCTAAT) of intron 20. The novel C variant (IVS20+657C) is not co-segregating with disease in Table 3 ) 32417688[GC(C/T)GG] Promoter C : 7/10 ; T : 3/10 32416574[GG(A/G)CT] 5k-UTR (see Table 3 IVS4+1008 (see Table 3 Results are shown for two affected members of family 11, and three controls (in total 10 chromosomes) studied by mutational analysis in the first step. Of the two polymorphisms already present in the databases, and indicated by asterisks (*rs4371122, **rs2705357), only one allele was found in this sample. family 11. However, an additional thymidine residue was found in a thymidine stretch adjacent to an intronic TATCAAT motif [5k-GATTTTTT(insT)ATC-AAT-3k], another putative branch site that is localized 22 bp upstream of the splice acceptor site of the intron 4 intervening sequence (IVS4) of the gene. The relatively rare IVS4+1008ins(T) variant was present in all seven affected members of the large pedigree 11 ( Figure 1 ) and was studied in more detail due to its putative functional relevance, as were both putatively functional G variants in promoter and 5k-UTR (see Tables 1-4) To assess the possible effects of these variants in the pathogenesis of schizophrenia and affective disorders, we conducted a case-control association study. For 32418760G, 186 cases and 318 controls were genotyped, for 32416574G, 186 cases and 346 controls were genotyped, and for IVS4+1008ins(T), 181 cases and 266 controls were genotyped.
As the promotor and the 5k-UTR variants (32418760G and 32416574G) and the intron variant IVS4+1008ins(T) showed strong linkage disequilibrium (LD ; Table 2), first, the association of the haplotypes with both disorders and the combined sample was assessed. otype of the three variants 32418760G, 32416574G and IVS4+1008ins(T) was associated with the bipolar subsample. For the haplotypes containing only two variants, association was found for the ones including 32418760G in the bipolar subsample. A trend for association of these haplotypes with the combined sample was also found. As shown in Table 4 , the two G variants were less abundant compared to IVS4+1008ins(T), thus rarely leading to the occurrence of the combined haplotype. As genotyping rates differed between the variants, and LD was least strong with the intron variant IVS4+1008ins(T), an additional single marker analysis was conducted, which showed association of 32418760G in the bipolar disorder subsample and the combined sample and also a trend for an association of 32416574G in those samples (Table 4) . No clinical differences were found in patients carrying the rare variants, and those who were not carriers.
Discussion
Based on the hypothesis that specific genes may cause both neuropathies and psychoses (Delpire and Mount, 2002 ; Meyer et al., 2002b) , we have selected variants of SLC12A6 for association studies with schizophrenia spectrum and bipolar disorder. This gene was chosen as a candidate, since it is located in a candidate region for schizophrenia and bipolar affective disorder on chromosome 15q14. Furthermore, recessive mutations in SLC12A6 were shown to cause severe peripheral neuropathy with or without agenesis of the corpus callosum (Andermann syndrome, ACCPN, OMIM 218000) (Howard et al., 2002) , which is frequently associated with psychoses (Filteau et al., 1991) . Previously, a considerable amount of overlapping chromosomal loci for both bipolar disorder and schizophrenia has been shown (for review, see Berrettini, 2000 ; Klar, 2001) . Additionally, periodic catatonia (SCZD10) and manic-depressive disorder share bipolarity as a typical feature (Fink and Taylor, 2001) .
We have detected three variants of SLC12A6 co-segregating with disease in a multiplex family with schizophrenia of periodic catatonia type. These were further assessed for association in two patient samples with either schizophrenia or bipolar disorder, and the combined patient sample, diagnosed according to ICD-10, of German origin. Our finding of associated three and two variant haplotypes in bipolar disorder supports the hypothesis of a close relationship of periodic catatonia and bipolar disorder. Because of the fluctuating phenotype with periods of so-called 'positive ' and ' negative ' symptoms, periodic catatonia might be more related to the bipolar spectrum disorders than to schizophrenia (Taylor and Fink, 2003) . However, these findings do not allow a final judgement as to whether periodic catatonia is a true nosological entity or not. Due to the association findings, the promoter polymorphism itself, or haplotypes containing this polymorphism may influence pathogenesis directly. As the 5k-UTR SNP also showed a trend towards association with bipolar disorder, this polymorphism may either influence pathogenesis, or the association may be due to strong LD between both G variants. Our finding of an association of SLC12A6 implicated in agenesis of the corpus callosum further supports the developmental hypothesis of mental disorders.
A few limitations of our study should be addressed. Our finding may represent a false-positive result due to population stratification (Lander and Schork, 1994) . However, stratification seems unlikely since both patients and controls originate from the same narrow area around Wuerzburg, Germany, which is inhabited by a homogenous Franconian population. Furthermore, both rare G variants may be in LD with the 'true ' disease causing mutation, which could then be expected distantly to the SLC12A6 locus, since another large family (family 9 ; Stö ber et al., 2002) with five affected members supports a region of 7.7 cM between markers D15S1042 and D15S182 distally of SLC12A6 (Meyer et al., 2003) . Alternatively, a second susceptibility gene for SCZD10 may be located on chromosome 15, and be responsible for the disease in family 9. However, the distance between SLC12A6 and marker D15S1042 representing the upper limit for linkage in family 9 spans y1.6 Mb, whereas LD in the general population could be expected for intervals from 3 to 100 kb (Kruglyak, 1999 ; Ott, 2000 ; Reich et al., 2001) .
Our finding supports the view of Liu and colleagues (2005) , that rare variants should not be ignored in genetic studies of complex diseases. However, since our sample size is relatively small, replication of the results of the association study is needed. In particular, the borderline association found with the schizophrenia subsample is worthy of being evaluated in an independent study.
Taken together, our data combined with the results of others provide evidence that SLC12A6 should be considered as a risk gene for developing manic-depressive disorder. In the single marker analysis, the strongest association was found for the promoter 32418760G/A polymorphism. Preliminary results indicate that the CpG site created by the Cases, n=number of affected individuals ; controls, n=number of controls. G allele is methylated in peripheral blood lymphocytes, thus suggesting a putative regulatory function of the 32418760G promoter variant (Moser et al., unpublished observations). Therefore, SLC12A6 should be regarded as one of the susceptibility genes in this chromosomal region responsible for the pathogenesis of bipolar disorder, and, perhaps, schizophrenia with bipolar features.
